Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 10, 15:57
426.70
-5.05 (-1.17%)
VOLUME 251,044
LIVE
NSE
Jul 10, 16:05
426.65
-5.3 (-1.23%)
VOLUME 3,395,204
News on Glenmark Pharma
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sell Glenmark Pharmaceuticals; target of Rs 365: Prabhudas Lilladher

1.52 pm | 02 Jul 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 365 in its research repo...

Neutral Glenmark Pharma; target of Rs 430: Motilal Oswal

11.02 am | 01 Jul 2020 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 430 in its research report dated June 29, 2020....

Glenmark Pharma share price tumbles 5% on price-fixing allegations in US

10.37 am | 01 Jul 2020 |  Source: Moneycontrol.com

The charge was filed in US District Court in Philadelphia. The price-fixing conspiracy allegedly took place from 2013 to 2015 and caused a loss to vic...

Buy Glenmark Pharma; target of Rs 526: Emkay Global Financial

10.31 am | 01 Jul 2020 |  Source: Moneycontrol.com

Emkay Global Financial is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 526 in its research report date...

US charges generic drug firm Glenmark with price-fixing

9.52 am | 01 Jul 2020 |  Source: Reuters

Glenmark allegedly conspired with pharmaceutical maker Apotex Corp and other generic drug companies to increase the prices of cholesterol medication p...

Glenmark Pharma falls 5% on CLSA downgrade after Q4 earnings

3.30 pm | 30 Jun 2020 |  Source: Moneycontrol.com

Glenmark reported 36 percent year-on-year increase in Q4FY20 profit at Rs 220 crore and 8 percent growth in revenue at Rs 2,764 crore during the quart...

Glenmark Standalone March 2020 Net Sales at Rs 1,607.73 crore, up 1.29% Y-o-Y

11.11 am | 29 Jun 2020 |  Source: Moneycontrol.com

NULL...

Glenmark Consolidated March 2020 Net Sales at Rs 2,767.49 crore, up 7.96% Y-o-Y

10.15 am | 29 Jun 2020 |  Source: Moneycontrol.com

NULL...

Glenmark Pharma Q4 net profit jumps 36% to Rs 220 crore

10.41 pm | 26 Jun 2020 |  Source: PTI

The company's consolidated revenue for the quarter rose 7.96 per cent to Rs 2,767.48 crore as against Rs 2,563.47 crore a year ago, Glenmark Pharm...

Buy Glenmark Pharma; target of Rs 488: ICICI Securities

7.49 am | 25 Jun 2020 |  Source: Moneycontrol.com

ICICI Securities is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 488 in its research report dated June...

Glenmark Pharma corrects 7% on profit booking

12.59 pm | 24 Jun 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher says 27 percent rally in the stock on June 22 was an "irrational exuberance" and would likely fizzle out....

Sell Glenmark Pharmaceuticals; target of Rs 257: Prabhudas Lilladher

7.50 pm | 23 Jun 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 257 in its research repo...

Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

8.27 pm | 22 Jun 2020 |  Source: PTI

Dr Avi Kumar, Consultant, Pulmonologist, Fortis Escort Heart Institute, said drugs such as Favipiravir and Remdisiver "cannot be called game changers"...

Glenmark shares end 27% higher after regulator's nod for COVID-19 drug

10.10 am | 22 Jun 2020 |  Source: Moneycontrol.com

The pharma company said that it has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate...

Glenmark Pharmaceuticals gets India approval for favipiravir as COVID-19 treatment

8.50 pm | 19 Jun 2020 |  Source: Reuters

The Mumbai-based company said the approval was part of India's accelerated approval process and the drug was meant for "restricted emergency use,"...

Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules

9.57 am | 19 Jun 2020 |  Source: PTI

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod Capsules, ...

Buy Glenmark Pharmaceuticals; target of Rs 410: Globe Capital Market

11.32 am | 02 Jun 2020 |  Source: Moneycontrol.com

Globe Capital Market is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 410 in its research repo...

1
Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.